1887

Abstract

Tick-borne encephalitis virus (TBEV), a member of the genus , is common in Europe and Asia and causes a severe disease of the central nervous system. A promising approach in the development of therapy for TBEV infection is the search for small molecule antivirals targeting the flavivirus envelope protein E, particularly its β--octyl--glucoside binding pocket (β-OG pocket). However, experimental studies of candidate antivirals may be complicated by varying amounts and different forms of the protein E in the virus samples. Viral particles with different conformations and arrangements of the protein E are produced during the replication cycle of flaviviruses, including mature, partially mature, and immature forms, as well as subviral particles lacking genomic RNA. The immature forms are known to be abundant in the viral population. We obtained immature virion preparations of TBEV, characterized them by RTPCR, and assessed and infectivity of the residual mature virions in the immature virus samples. Analysis of the β-OG pocket structure on the immature virions confirmed the possibility of binding of adamantylmethyl esters of 5-aminoisoxazole-3-carboxylic acid in the pocket. We demonstrated that the antiviral activity of these compounds in plaque reduction assay is significantly reduced in the presence of immature TBEV particles.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001658
2021-09-21
2021-10-24
Loading full text...

Full text loading...

References

  1. Deviatkin AA, Karganova GG, Vakulenko YA, Lukashev AN. TBEV subtyping in terms of genetic distance. Viruses 2020; 12:1240
    [Google Scholar]
  2. Ruzek D, Avšič Županc T, Borde J, Chrdle A, Eyer L et al. Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines. Antiviral Res 2019; 164:23–51 [View Article] [PubMed]
    [Google Scholar]
  3. Pulkkinen L, Butcher SJ, Anastasina M. Tick-borne encephalitis virus: a structural view. Viruses 2018; 10:350 [View Article]
    [Google Scholar]
  4. Botting C, Kuhn RJ. Novel approaches to flavivirus drug discovery. Expert Opin Drug Discov 2012; 7:417–428 [View Article] [PubMed]
    [Google Scholar]
  5. Füzik T, Formanová P, Růžek D, Yoshii K, Niedrig M et al. Structure of tick-borne encephalitis virus and its neutralization by a monoclonal antibody. Nat Commun 2018; 9:436 [View Article] [PubMed]
    [Google Scholar]
  6. Rey FA, Heinz F, Mandl C, Kunz C, Harrison SC. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 1995; 375:291–298 [View Article] [PubMed]
    [Google Scholar]
  7. Maldov DG, Karganova GG, Timofeev A. Tick-borne encephalitis virus interaction with the target cells. Arch Virol 1992; 127:321–325 [View Article] [PubMed]
    [Google Scholar]
  8. Perera-Lecoin M, Meertens L, Carnec X, Amara A. Structure of the immature Zika virus at 9 Å resolution. Nat Struct Mol Biol 2013; 24:88 [View Article]
    [Google Scholar]
  9. Kuhn RJ, Zhang W, Rossmann MG, Pletnev S, Corver J et al. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 2002; 108:717–725 [View Article] [PubMed]
    [Google Scholar]
  10. Mukhopadhyay S, Kuhn RJ, Rossmann MG. A structural perspective of the flavivirus life cycle. Nat Rev Microbiol 2005; 3:13–22 [View Article] [PubMed]
    [Google Scholar]
  11. Kaufmann B, Chipman PR, Holdaway HA, Johnson S, Fremont DH et al. Capturing a flavivirus pre-fusion intermediate. PLoS Pathog 2009; 5:e1000672 [View Article] [PubMed]
    [Google Scholar]
  12. Allison SL, Schalich J, Stiasny K, Mandl CW, Kunz C et al. Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH. J Virol 1995; 69:695–700 [View Article] [PubMed]
    [Google Scholar]
  13. Modis Y, Ogata S, Clements D, Harrison SC. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci U S A 2003; 100:6986–6991 [View Article] [PubMed]
    [Google Scholar]
  14. Modis Y, Ogata S, Clements D, Harrison SC. Structure of the dengue virus envelope protein after membrane fusion. Nature 2004; 427:313–319 [View Article] [PubMed]
    [Google Scholar]
  15. Kuhn RJ, Dowd KA, Beth Post C, Pierson TC. Shake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the host. Virology 2015 479–480 508–517 [View Article] [PubMed]
    [Google Scholar]
  16. Kostyuchenko VA, Zhang Q, Tan JL, Ng T-S, Lok S-M. Immature and mature dengue serotype 1 virus structures provide insight into the maturation process. J Virol 2013; 87:7700–7707 [View Article] [PubMed]
    [Google Scholar]
  17. Prasad VM, Miller AS, Klose T, Sirohi D, Buda G et al. Structure of the immature Zika virus at 9 Å resolution. Nat Struct Mol Biol 2017; 24:184–186
    [Google Scholar]
  18. Zhang Y, Kaufmann B, Chipman PR, Kuhn RJ, Rossmann MG. Structure of immature West Nile virus. J Virol 2007; 81:6141–6145 [View Article] [PubMed]
    [Google Scholar]
  19. Renner M, Dejnirattisai W, Carrique L, Martin IS. A high resolution view of an adolescent flavivirus; 2020
  20. Bressanelli S, Stiasny K, Allison SL, Stura EA, Duquerroy S et al. Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J 2004; 23:728–738 [View Article] [PubMed]
    [Google Scholar]
  21. Décembre E, Assil S, Hillaire MLB, Dejnirattisai W, Mongkolsapaya J et al. Sensing of immature particles produced by dengue virus infected cells induces an antiviral response by plasmacytoid dendritic cells. PLoS Pathog 2014; 10:e1004434 [View Article] [PubMed]
    [Google Scholar]
  22. Cherrier M, Kaufmann B, Nybakken GE, Lok S-M, Warren JT et al. Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody. EMBO J 2009; 28:3269–3276 [View Article] [PubMed]
    [Google Scholar]
  23. Junjhon J, Edwards TJ, Utaipat U, Bowman VD, Holdaway HA et al. Influence of pr-M cleavage on the heterogeneity of extracellular dengue virus particles. J Virol 2010; 84:8353–8358 [View Article] [PubMed]
    [Google Scholar]
  24. Li Z, Khaliq M, Zhou Z, Post CB, Kuhn RJ et al. Design, synthesis, and biological evaluation of antiviral agents targeting flavivirus envelope proteins. J Med Chem 2008; 51:4660–4671 [View Article] [PubMed]
    [Google Scholar]
  25. Osolodkin D, Kozlovskaya L, Dueva E, Dotsenko V, Rogova Y et al. Inhibitors of tick-borne flavivirus reproduction from structure-based virtual screening. ACS Med Chem Lett 2013; 4:869–874 [View Article] [PubMed]
    [Google Scholar]
  26. Zhou Z, Khaliq M, Suk J-E, Patkar C, Li L et al. Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein. ACS Chem Biol 2008; 3:765–775 [View Article] [PubMed]
    [Google Scholar]
  27. de Wispelaere M, Lian W, Potisopon S, Li P-C, Jang J et al. Inhibition of flaviviruses by targeting a conserved pocket on the viral envelope protein. Cell Chem Biol 2018; 25:1006–1016 [View Article] [PubMed]
    [Google Scholar]
  28. Dueva EV, Osolodkin DI, Kozlovskaya LI, Palyulin VA, Pentkovski VM et al. Interaction of flaviviruses with reproduction inhibitors binding in β-OG pocket: Insights from molecular dynamics simulations. Mol Inform 2014; 33:695–708 [View Article] [PubMed]
    [Google Scholar]
  29. Vasilenko DA, Dueva E, Kozlovskaya L, Zefirov NA, Grishin YK et al. Tick-borne flavivirus reproduction inhibitors based on isoxazole core linked with adamantane. Bioorg Chem 2019; 87:629–637 [View Article] [PubMed]
    [Google Scholar]
  30. Dueva E, Tuchynskaya KK, Kozlovskaya L, Osolodkin D, Sedenkova KN et al. Spectrum of antiviral activity of 4-aminopyrimidine N-oxides against a broad panel of tick-borne encephalitis virus strains. Antivir Chem Chemother 2020; 28:
    [Google Scholar]
  31. Tuchynskaya K, Volok V, Illarionova V, Okhezin E, Polienko A et al. Experimental assessment of possible factors associated with tick-borne encephalitis vaccine failure. Microorganisms 2021; 9: [View Article] [PubMed]
    [Google Scholar]
  32. Pierson TC, Diamond MS. Degrees of maturity: the complex structure and biology of flaviviruses. Curr Opin Virol 2012; 2:168–175 [View Article] [PubMed]
    [Google Scholar]
  33. Romanova L, Gmyl AP, Dzhivanian T, Bakhmutov D, Lukashev AN et al. Microevolution of tick-borne encephalitis virus in course of host alternation. Virology 2007; 362:75–84 [View Article] [PubMed]
    [Google Scholar]
  34. Shevtsova AS, Motuzova OV, Kuragina VM, Akhmatova NK, Gmyl LV et al. Lethal experimental tick-borne encephalitis infection: Influence of two strains with similar virulence on the immune response. Front Microbiol 2016; 7:2172 [View Article] [PubMed]
    [Google Scholar]
  35. Heinz F, Stiasny K, Püschner-Auer G, Holzmann H, Allison SL et al. Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM. Virology 1994; 198:109–117 [View Article] [PubMed]
    [Google Scholar]
  36. Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints12. Am J Epidemiol 1938; 27:493–497 [View Article]
    [Google Scholar]
  37. Gmyl AP, Korshenko SA, Belousov E, Khitrina E, Agol V. Nonreplicative homologous RNA recombination: promiscuous joining of RNA pieces. RNA 2003; 9:1221–1231 [View Article] [PubMed]
    [Google Scholar]
  38. Nikitin N, Trifonova E, Evtushenko E, Kirpichnikov M, Atabekov J et al. Comparative study of non-enveloped icosahedral viruses size. PLoS One 2015; 10:e0142415 [View Article] [PubMed]
    [Google Scholar]
  39. Belova OA, Litov AG, Kholodilov IS, Kozlovskaya L, Bell-Sakyi L et al. Properties of the tick-borne encephalitis virus population during persistent infection of ixodid ticks and tick cell lines. Ticks Tick Borne Dis 2017; 8:895–906 [View Article] [PubMed]
    [Google Scholar]
  40. Lorenz RJ, Bögel K. Laboratory techniques in rabies: methods of calculation. Monograph Series World Health Organization 1973; 23:321–335
    [Google Scholar]
  41. Sali A, Blundell TL. Comparative protein modeling by satisfaction of spatial restraints. J Mol Biol 1993; 234:779–815 [View Article] [PubMed]
    [Google Scholar]
  42. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007; 23:2947–2948 [View Article] [PubMed]
    [Google Scholar]
  43. Shen M-Y, Sali A. Statistical potential for assessment and prediction of protein structures. Protein Sci 2006; 15:2507–2524 [View Article] [PubMed]
    [Google Scholar]
  44. Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 1993; 26:283–291
    [Google Scholar]
  45. Pettersen EF, Goddard TD, Huang CC. UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem 2004
    [Google Scholar]
  46. Kelley LA, Gardner SP, Sutcliffe MJ. An automated approach for clustering an ensemble of NMR-derived protein structures into conformationally related subfamilies. Protein Eng 1996; 9:1063–1065 [View Article] [PubMed]
    [Google Scholar]
  47. Sedenkova KN, Dueva EV, Averina EB, Grishin YK, Osolodkin DI et al. Synthesis and assessment of 4-aminotetrahydroquinazoline derivatives as tick-borne encephalitis virus reproduction inhibitors. Org Biomol Chem 2015; 13:3406–3415 [View Article]
    [Google Scholar]
  48. Meng EC, Pettersen EF, Couch GS, Huang CC, Ferrin TE. Tools for integrated sequence-structure analysis with UCSF Chimera. BMC Bioinformatics 2006; 7:339 [View Article] [PubMed]
    [Google Scholar]
  49. Allen WJ, Balius TE, Mukherjee S, Brozell SR, Moustakas DT et al. DOCK 6: Impact of new features and current docking performance. J Comput Chem 2015; 36:1132–1156 [View Article] [PubMed]
    [Google Scholar]
  50. Kuntz ID, Blaney JM, Oatley SJ, Langridge R, Ferrin TE. A geometric approach to macromolecule-ligand interactions. J Mol Biol 1982; 161 :269–288 [View Article] [PubMed]
    [Google Scholar]
  51. Software Solutions and Services for Chemistry & Biology; 2020 https://www.chemaxon.com
  52. Hanwell MD, Curtis DE, Lonie DC, Vandermeersch T, Zurek E et al. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J Cheminform 2012; 4:17 [View Article] [PubMed]
    [Google Scholar]
  53. Halgren TA. MMFF VI. MMFF94s option for energy minimization studies. J Comput Chem 1999; 20:720–729 [View Article]
    [Google Scholar]
  54. Halgren TA. Merck molecular force field. II. MMFF94 van der Waals and electrostatic parameters for intermolecular interactions. J Comput Chem 1996; 17:520–552
    [Google Scholar]
  55. Seaborn distplot — seaborn 0.11.1 documentation; 2020 https://seaborn.pydata.org/generated/seaborn.distplot.html
  56. Allison SL, Tao YJ, O’Riordain G, Mandl CW, Harrison SC et al. Two distinct size classes of immature and mature subviral particles from tick-borne encephalitis virus. J Virol 2003; 77:11357–11366 [View Article] [PubMed]
    [Google Scholar]
  57. Morrone SR, Lok S-M. Structural perspectives of antibody-dependent enhancement of infection of dengue virus. Curr Opin Virol 2019; 36:1–8 [View Article] [PubMed]
    [Google Scholar]
  58. Dowd KA, Pierson TC. The many faces of a dynamic virion: Implications of viral breathing on flavivirus biology and immunogenicity. Annu Rev Virol 2018; 5:185–207 [View Article] [PubMed]
    [Google Scholar]
  59. Raut R, Corbett KS, Tennekoon RN, Premawansa S, Wijewickrama A et al. Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies. Proc Natl Acad Sci U S A 2019; 116:227–232 [View Article] [PubMed]
    [Google Scholar]
  60. Rey FA, Stiasny K, Heinz F. Flavivirus structural heterogeneity: implications for cell entry. Curr Opin Virol 2017; 24:132–139 [View Article] [PubMed]
    [Google Scholar]
  61. Rodenhuis-Zybert IA, van der Schaar HM, da Silva Voorham JM, van der Ende-Metselaar H, Lei H-Y et al. Immature dengue virus: a veiled pathogen?. PLoS Pathogens 2010; 6:e1000718
    [Google Scholar]
  62. Heinz FX, Stiasny K. The antigenic structure of Zika virus and its relation to other flaviviruses: Implications for infection and immunoprophylaxis. Microbiol Mol Biol Rev 2017; 81: [View Article] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001658
Loading
/content/journal/jgv/10.1099/jgv.0.001658
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error